82 related articles for article (PubMed ID: 11961896)
21. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
Mutalik S; Udupa N
J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
[TBL] [Abstract][Full Text] [Related]
22. [Influence of progestins on adverse effects of oral contraceptives].
Wynn V
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
[TBL] [Abstract][Full Text] [Related]
23. Low-dose transdermal hormone therapy does not interfere with the blood pressure of hypertensive menopausal women: a pilot study.
de Carvalho MN; Nobre F; Mendes MC; Dos Reis RM; Ferriani RA; Silva de Sá MF
Blood Press Monit; 2008 Oct; 13(5):277-83. PubMed ID: 18799953
[TBL] [Abstract][Full Text] [Related]
24. [The use of transdermal therapeutic systems in physical therapy].
Jankowska K; Delewska A; Klimkiewicz R; Kubsik A; Woldańska-Okońska M
Pol Merkur Lekarski; 2013 Sep; 35(207):175-8. PubMed ID: 24224458
[TBL] [Abstract][Full Text] [Related]
25. Advances in psychotropic formulations.
Keith S
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):996-1008. PubMed ID: 16678954
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of safety and efficacy of transdermal therapeutic system-fentanyl in adult patients with gynecological cancer-related pain.
Lorvidhaya V; Katanyoo K; Srisomboon J; Suprapaphorn P; Cheewakriangkrai C
J Med Assoc Thai; 2004 Mar; 87(3):319-25. PubMed ID: 15117050
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy plus either transdermal fentanyl or paracetamol and codeine for painful bone metastases: a randomised study of pain relief and quality of life.
Pistevou-Gompaki K; Kouloulias VE; Varveris C; Mystakidou K; Georgakopoulos G; Eleftheriadis N; Gompakis N; Kouvaris J
Curr Med Res Opin; 2004; 20(2):159-63. PubMed ID: 15006009
[TBL] [Abstract][Full Text] [Related]
28. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
29. Ephemeral profiles of prescription drug and formulation tampering: evolving pseudoscience on the Internet.
Cone EJ
Drug Alcohol Depend; 2006 Jun; 83 Suppl 1():S31-9. PubMed ID: 16458455
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of constant current alternating current iontophoresis for transdermal drug delivery.
Yan G; Li SK; Higuchi WI
J Control Release; 2005 Dec; 110(1):141-50. PubMed ID: 16289410
[TBL] [Abstract][Full Text] [Related]
31. Transdermal therapeutic fentanyl-system (TTS-F).
Mystakidou K; Katsouda E; Tsilika E; Parpa E; Vlahos L
In Vivo; 2004; 18(5):633-42. PubMed ID: 15523905
[TBL] [Abstract][Full Text] [Related]
32. Sonophoresis: recent advancements and future trends.
Rao R; Nanda S
J Pharm Pharmacol; 2009 Jun; 61(6):689-705. PubMed ID: 19505359
[TBL] [Abstract][Full Text] [Related]
33. Hormonal contraception: state of the art and future perspectives.
Benagiano G; Bastianelli C; Farris M
Minerva Ginecol; 2007 Jun; 59(3):241-70. PubMed ID: 17576403
[TBL] [Abstract][Full Text] [Related]
34. Hormonal contraception: recent advances and controversies.
Practice Committee of the American Society for Reproductive Medicine
Fertil Steril; 2006 Nov; 86(5 Suppl 1):S229-35. PubMed ID: 17055831
[TBL] [Abstract][Full Text] [Related]
35. Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute.
Wokovich AM; Prodduturi S; Doub WH; Hussain AS; Buhse LF
Eur J Pharm Biopharm; 2006 Aug; 64(1):1-8. PubMed ID: 16797171
[TBL] [Abstract][Full Text] [Related]
36. In vivo characterization of monolithic matrix type transdermal drug delivery systems of pinacidil monohydrate: a technical note.
Aqil M; Ali A; Sultana Y; Dubey K; Najmi AK; Pillai KK
AAPS PharmSciTech; 2006 Jan; 7(1):E6. PubMed ID: 16584165
[TBL] [Abstract][Full Text] [Related]
37. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations.
Escobar-Chávez JJ; López-Cervantes M; Naïk A; Kalia YN; Quintanar-Guerrero D; Ganem-Quintanar A
J Pharm Pharm Sci; 2006; 9(3):339-58. PubMed ID: 17207417
[TBL] [Abstract][Full Text] [Related]
38. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
Mittal A; Sara US; Ali A; Mohammed A
Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
[TBL] [Abstract][Full Text] [Related]
39. Buprenorphine and the transdermal system: the ideal match in pain management.
Budd K
Int J Clin Pract Suppl; 2003 Feb; (133):9-14; discussion 23-4. PubMed ID: 12665118
[TBL] [Abstract][Full Text] [Related]
40. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
Otis J; Rothman M
Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
